Marta Najmanowicz, Weronika Gajda, Aleksandra Nowatkowska, Mikołaj Kamiński, Aleksandra Cieluch, Alicja Sroczyńska, Anna Kreczmer, Magdalena Michalak, Anna Adamska, Urszula Frąckowiak, Mateusz Michalski, Aleksandra Araszkiewicz, Dorota Zozulińska-Ziółkiewicz, Andrzej Gawrecki
{"title":"在“胰岛素泵周”期间参加GoPump结构化糖尿病教育计划的1型糖尿病患者的横断面评估","authors":"Marta Najmanowicz, Weronika Gajda, Aleksandra Nowatkowska, Mikołaj Kamiński, Aleksandra Cieluch, Alicja Sroczyńska, Anna Kreczmer, Magdalena Michalak, Anna Adamska, Urszula Frąckowiak, Mateusz Michalski, Aleksandra Araszkiewicz, Dorota Zozulińska-Ziółkiewicz, Andrzej Gawrecki","doi":"10.5114/pedm.2025.148400","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Despite advances in therapy, most persons with type 1 diabetes (PwT1Ds) do not achieve treatment goals. Education is fundamental to the care of PwT1Ds treated with continuous subcutaneous insulin infusion (CSII).</p><p><strong>Aim of the study: </strong>To evaluate PwT1Ds treated with CSII and receiving in-hospital education and to identify factors associated with treatment effectiveness.</p><p><strong>Material and methods: </strong>This cross-sectional study included adults with type 1 diabetes (T1D), who received diabetes education using the proprietary Structured Diabetes Education Program, GoPump, during \"Insulin Pump Weeks\" in 2022-2023. Metabolic control of diabetes was evaluated. Reports from personal insulin pumps, blood glucose meters, and continuous glucose monitoring (CGM) systems were assessed.</p><p><strong>Results: </strong>Data from 107 individuals with a median age of 26.7 years (Q1-Q3: 19.0-30.8) were analysed, including 65 women (60.7%). The median duration of T1D was 13 years (Q1-Q3: 10.0-18.0), and the median duration of personal insulin pump use was 8 years (Q1-Q3: 5.0-12.0). The median body mass index was 23.9 kg/m². CGM was used by 52.3% of individuals. The median time in range (TIR) was 57.0% (Q1-Q3: 45.0-69.5%), and the median glycated haemoglobin (HbA1c) level was 7.9% (Q1-Q3: 6.8-8.5%). A positive correlation was found between age and TIR (rs = 0.42, p = 0.001). The use of temporary basal rate and dual-wave and square bolus features was positively correlated with TIR (rs = 0.34, p = 0.012 and rs = 0.31, p = 0.021, respectively) and inversely with time above range > 250 mg/dl (rs = -0.37, p = 0.007 and rs = -0.27, p = 0.045, respectively). Lower HbA1c levels were observed in individuals with a higher number of daily boluses (rs = -0.33, p = 0.001).</p><p><strong>Conclusions: </strong>In the study cohort, older age, more frequent use of advanced insulin pump features, and a higher number of daily boluses were associated with better glycaemic control in adults with T1D.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"31 1","pages":"1-8"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12051104/pdf/","citationCount":"0","resultStr":"{\"title\":\"Cross-sectional evaluation of people with type 1 diabetes participating in the GoPump Structured Diabetes Education Program during \\\"Insulin Pump Weeks\\\".\",\"authors\":\"Marta Najmanowicz, Weronika Gajda, Aleksandra Nowatkowska, Mikołaj Kamiński, Aleksandra Cieluch, Alicja Sroczyńska, Anna Kreczmer, Magdalena Michalak, Anna Adamska, Urszula Frąckowiak, Mateusz Michalski, Aleksandra Araszkiewicz, Dorota Zozulińska-Ziółkiewicz, Andrzej Gawrecki\",\"doi\":\"10.5114/pedm.2025.148400\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Despite advances in therapy, most persons with type 1 diabetes (PwT1Ds) do not achieve treatment goals. Education is fundamental to the care of PwT1Ds treated with continuous subcutaneous insulin infusion (CSII).</p><p><strong>Aim of the study: </strong>To evaluate PwT1Ds treated with CSII and receiving in-hospital education and to identify factors associated with treatment effectiveness.</p><p><strong>Material and methods: </strong>This cross-sectional study included adults with type 1 diabetes (T1D), who received diabetes education using the proprietary Structured Diabetes Education Program, GoPump, during \\\"Insulin Pump Weeks\\\" in 2022-2023. Metabolic control of diabetes was evaluated. Reports from personal insulin pumps, blood glucose meters, and continuous glucose monitoring (CGM) systems were assessed.</p><p><strong>Results: </strong>Data from 107 individuals with a median age of 26.7 years (Q1-Q3: 19.0-30.8) were analysed, including 65 women (60.7%). The median duration of T1D was 13 years (Q1-Q3: 10.0-18.0), and the median duration of personal insulin pump use was 8 years (Q1-Q3: 5.0-12.0). The median body mass index was 23.9 kg/m². CGM was used by 52.3% of individuals. The median time in range (TIR) was 57.0% (Q1-Q3: 45.0-69.5%), and the median glycated haemoglobin (HbA1c) level was 7.9% (Q1-Q3: 6.8-8.5%). A positive correlation was found between age and TIR (rs = 0.42, p = 0.001). The use of temporary basal rate and dual-wave and square bolus features was positively correlated with TIR (rs = 0.34, p = 0.012 and rs = 0.31, p = 0.021, respectively) and inversely with time above range > 250 mg/dl (rs = -0.37, p = 0.007 and rs = -0.27, p = 0.045, respectively). Lower HbA1c levels were observed in individuals with a higher number of daily boluses (rs = -0.33, p = 0.001).</p><p><strong>Conclusions: </strong>In the study cohort, older age, more frequent use of advanced insulin pump features, and a higher number of daily boluses were associated with better glycaemic control in adults with T1D.</p>\",\"PeriodicalId\":39165,\"journal\":{\"name\":\"Pediatric Endocrinology, Diabetes and Metabolism\",\"volume\":\"31 1\",\"pages\":\"1-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12051104/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Endocrinology, Diabetes and Metabolism\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/pedm.2025.148400\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Endocrinology, Diabetes and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/pedm.2025.148400","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
导读：尽管治疗取得了进展，但大多数1型糖尿病患者（PwT1Ds）并没有达到治疗目标。教育是持续皮下胰岛素输注（CSII）治疗的PwT1Ds护理的基础。本研究的目的：评估接受CSII治疗的PwT1Ds和接受住院教育的情况，并确定与治疗效果相关的因素。材料和方法：本横断面研究纳入了2022-2023年“胰岛素泵周”期间使用专有的结构化糖尿病教育计划GoPump接受糖尿病教育的1型糖尿病（T1D）成人。评估糖尿病的代谢控制。评估个人胰岛素泵、血糖仪和连续血糖监测（CGM）系统的报告。结果：分析了107例患者的数据，中位年龄为26.7岁（Q1-Q3: 19.0-30.8岁），其中65例为女性（60.7%）。T1D的中位病程为13年（Q1-Q3: 10.0-18.0），个人胰岛素泵使用的中位病程为8年（Q1-Q3: 5.0-12.0）。身体质量指数中位数为23.9 kg/m²。52.3%的人使用CGM。中位范围时间（TIR）为57.0% (Q1-Q3: 45.0-69.5%)，中位糖化血红蛋白（HbA1c）水平为7.9% （Q1-Q3: 6.8-8.5%）。年龄与TIR呈正相关（rs = 0.42, p = 0.001）。临时基础率、双波和方块特征的使用与TIR呈正相关（rs = 0.34, p = 0.012和rs = 0.31, p = 0.021），与时间高于> 250 mg/dl呈负相关（rs = -0.37, p = 0.007和rs = -0.27, p = 0.045）。在每日服用剂量较高的个体中，HbA1c水平较低（rs = -0.33, p = 0.001）。结论：在研究队列中，年龄越大，更频繁地使用先进的胰岛素泵功能，以及更多的每日剂量与T1D成人患者更好的血糖控制相关。
Cross-sectional evaluation of people with type 1 diabetes participating in the GoPump Structured Diabetes Education Program during "Insulin Pump Weeks".
Introduction: Despite advances in therapy, most persons with type 1 diabetes (PwT1Ds) do not achieve treatment goals. Education is fundamental to the care of PwT1Ds treated with continuous subcutaneous insulin infusion (CSII).
Aim of the study: To evaluate PwT1Ds treated with CSII and receiving in-hospital education and to identify factors associated with treatment effectiveness.
Material and methods: This cross-sectional study included adults with type 1 diabetes (T1D), who received diabetes education using the proprietary Structured Diabetes Education Program, GoPump, during "Insulin Pump Weeks" in 2022-2023. Metabolic control of diabetes was evaluated. Reports from personal insulin pumps, blood glucose meters, and continuous glucose monitoring (CGM) systems were assessed.
Results: Data from 107 individuals with a median age of 26.7 years (Q1-Q3: 19.0-30.8) were analysed, including 65 women (60.7%). The median duration of T1D was 13 years (Q1-Q3: 10.0-18.0), and the median duration of personal insulin pump use was 8 years (Q1-Q3: 5.0-12.0). The median body mass index was 23.9 kg/m². CGM was used by 52.3% of individuals. The median time in range (TIR) was 57.0% (Q1-Q3: 45.0-69.5%), and the median glycated haemoglobin (HbA1c) level was 7.9% (Q1-Q3: 6.8-8.5%). A positive correlation was found between age and TIR (rs = 0.42, p = 0.001). The use of temporary basal rate and dual-wave and square bolus features was positively correlated with TIR (rs = 0.34, p = 0.012 and rs = 0.31, p = 0.021, respectively) and inversely with time above range > 250 mg/dl (rs = -0.37, p = 0.007 and rs = -0.27, p = 0.045, respectively). Lower HbA1c levels were observed in individuals with a higher number of daily boluses (rs = -0.33, p = 0.001).
Conclusions: In the study cohort, older age, more frequent use of advanced insulin pump features, and a higher number of daily boluses were associated with better glycaemic control in adults with T1D.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
